WebINCB 3284 dimesylate is a potent, selective hCCR2 antagonist. Exhibits potent antagonism against monocyte chemoattractant molecule binding to hCCR2 and chemotaxis activity … WebINCB-3284 means the Compound referred to by Incyte as INCB-3284 as of the date of this Agreement, which Compound is as described in *** and as depicted on Schedule 1.27 …

Tivumecirnon _ MedChemExpress(MCE)--性能参数，报价/价格， …

WebINCB 3284 dimesylate is a potent, selective hCCR2 antagonist. Exhibits potent antagonism against monocyte chemoattractant molecule binding to hCCR2 and chemotaxis activity … Webincb 3284 dimesylate, n-2-3r-1-trans-4-hydroxy-4-6-methoxy-3-pyridinyl cyclohexyl-3-pyrrolidinyl amino-2-oxoethyl-3-trifluoromethyl-benzamide dimethanesulfonate, incb-3284 … sigma riding breeches

Product data sheet

WebINCB 3284 dimesylate is a potent, selective and orally bioavailable human CCR2 antagonist, inhibiting monocyte chemoattractant protein-1 binding to hCCR2, with an IC 50 of 3.7 nM. INCB 3284 dimesylate can be used in the research of acute liver failure. In vitro activity INCB3284 is a potent hCCR2 antagonist with IC 50 WebINCB 3284 is a potent, selective, and orally bioavailable antagonist of monocyte chemotactic protein- 1 binding to CCR2 (IC 50 = 3.7 nM). 1 For comparison, it has no significant inhibitor action at over 50 ion channels, transporters, GPCRs, and other chemokine receptors when tested at a concentration of 1 μM. 1 INCB 3284 inhibits chemotaxis in … Web93284, Under Implantable, Insertable, and Wearable Cardiac Device Evaluations. The Current Procedural Terminology (CPT ®) code 93284 as maintained by American Medical … the print logo